Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00790439Phase 2Withdrawn
A Phase 2 trial of ilb in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Planned start Jul 2008; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00790439.